Uncategorized

Roche scraps 2 Huntington’s studies, handing Ionis more bad news

Published

on

Roche’s decision to discontinue the Ionis-partnered trials came soon after the biotech sustained a late-stage failure in ATTR-CM.

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version